Archives: Customer Publications
Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy
Journal: Pharmaceutical Research (2021)
Research Areas: Drug research
Cell Lines: MDA-MD-231
Cytoplasmic localization of prostate-specific membrane antigen inhibitors may confer advantages for targeted cancer therapies
Journal: Cancer Research (2021)
Research Areas: Cytotoxicity
Cell Lines: LNCaP and 22Rv1
A novel ROCK inhibitor: off-target effects of metformin
Journal: Turkish Journal of Biology (2021)
Research Areas: Drug research
Cell Lines: HeLa and MCF-7
Monobutyl phthalate can induce autophagy and metabolic disorders by activating the ire1a-xbp1 pathway in zebrafish liver
Journal: Journal of Hazardous Materials (2021)
Research Areas: Toxicology
Cell Lines: Zebra fish (AB strain) liver cells
Snail Overexpression Alters the microRNA Content of Extracellular Vesicles Released from HT29 Colorectal Cancer Cells and Activates Pro-Inflammatory State In Vivo
Journal: Cancers (2021)
Research Areas: Cancer research
Cell Lines: HT-29
Cellular Effects of Cystatins
Research Areas: Cancer research
Monoclonal antibody 2C5 specifically targets neutrophil extracellular traps
Journal: mAbs (2020)
Research Areas: Cell Research
Cell Lines: HL-60
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration‐resistant prostate cancer
Journal: Molecular Oncology (2020)
Research Areas: Cancer research
Cell Lines: PC-3
Efficient and crucial quality control of HAP1 cell ploidy status
Journal: Biology Open (2020)
Research Areas: Cell Research
Cell Lines: HAP1
Smart drug combinations for cervical cancer: dual targeting of Bcl-2 family of proteins and aurora kinases
Journal: Am J Cancer Res (2020)
Research Areas: Cancer research
Cell Lines: HeLa